Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 13.50
Ask: 14.50
Change: -0.25 (-1.75%)
Spread: 1.00 (7.407%)
Open: 14.25
High: 14.00
Low: 13.75
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

Thu, 04th Jan 2024 12:09

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Retailers Next and JD Sports were the best and worst performing blue-chip stocks respectively, after both provided trading updates including the Christmas period.

US stocks were called to open higher, following the release of minutes from the latest Federal Reserve meeting, and before the first of a pair of monthly US employment readings on Thursday.

The FTSE 100 index was up 7.08, or 0.1%, at 7,689.41. The FTSE 250 was up 14.33 points, 0.1%, at 19,340.73, and the AIM All-Share was up 0.28 of a point, marginally up, at 754.34.

The Cboe UK 100 was up 0.1% at 767.56, the Cboe UK 250 was up 0.2% at 16,806.97, and the Cboe Small Companies was up 0.4% at 14,916.62.

The UK service economy had its best performance in six months in December, a strong end to the year which helped boost the wider private sector, numbers showed.

The final S&P Global UK services business activity index climbed to 53.4 points in December from 50.9 in November. This was above the 50.0 no-change mark for the second month running and above the earlier flash estimate of 52.7

The final seasonally adjusted S&P Global UK composite purchasing managers' index registered 52.1 points in December, up from 50.7 in November and above the neutral 50.0 value for the second month running. This beat last month's flash estimate for December of 51.7 points and marked the highest final reading since June.

"The further rebound in December's PMI suggests a recession should be narrowly avoided," said Pantheon Macroeconomics analyst Gabriella Dickens.

In European equities on Thursday, the CAC 40 in Paris was up 0.4%, while the DAX 40 in Frankfurt was up 0.3%.

The eurozone service sector's decline slowed marginally in December, according to survey data from S&P Global.

The latest HCOB services purchasing managers' index posted 48.8 points in December, rising marginally from 48.7 in November and marking the fifth consecutive monthly contraction. The figure remained below the 50-point no-change mark, but registered above the flash estimate of 48.1 points.

S&P Global said demand for services fell at the end of the year, while sales and new business receipts also declined.

The HCOB eurozone composite PMI - a weighted average of the eurozone's manufacturing and services PMIs - posted 47.6 points in December, unchanged from November, and remaining below the 50-point threshold.

Sterling was quoted at USD1.2705 at midday on Thursday, higher than USD1.2646 at the London equities close on Wednesday. The euro traded at USD1.0958, higher than USD1.0915. Against the yen, the dollar was quoted at JPY144.19, up from JPY143.50.

In the FTSE 100, Next rose 4.7%. The retailer said full price sales during November and December were better than it anticipated.

In a trading update covering the nine weeks to December 30, Next said full price sales were up 5.7% from a year earlier, which was GBP39 million than its previous guidance of a 2.0% rise for the period.

Next upped its full-year pretax profit guidance by GBP20 million, or 4.0% to GBP905 million compared to last year, saying GBP17 million of the lift comes from the sales beat to date and GBP3 million from an upgraded forecast for full price sales in January.

JD Sports plunged 23%, after cutting its profit outlook amid weaker-than-expected sales growth and gross margins.

The retailer said organic revenue was up 6.0% in the 22 weeks that ended December 30 on a constant currency basis from a year earlier, with like-for-like growth of 1.8%. This was slightly behind its expectations. The retailer expects organic revenue growth of around 8% for the year ending February 3.

As a result, it expects to report pretax profit and adjusted items of between GBP915 million and GBP935 million for the financial year. This falls short of market expectations of GBP1.04 billion, which back in September, JD Sports had said it expected to meet.

"Our key markets have seen increased promotional activity during the peak trading season, driven by a more cautious consumer, but we continue to grow market share," said JD Sports Chief Executive Officer Regis Schultz.

"We are confident in our strategy and we continue to invest in our supply chain, systems and stores, supported by our strong cash generation and healthy balance sheet."

Oil majors BP and Shell rose 1.8% and 0.9% respectively, tracking higher oil prices. Brent oil bought USD78.87 a barrel early Thursday, higher than USD78.13 on Wednesday, as traders assess latest developments in the Middle East.

"The region remains a tinder box due to the Israel-Gaza war, and disruption to shipping routes through the Red Sea is also a key factor behind the surge in crude," AJ Bell analyst Russ Mould commented.

Among London's small-cap stocks, Topps Tiles lost 7.0%.

The retailer said sales in the 13 weeks ended December 30 were down 4.0% from a year earlier, with like-for-like sales down 7.1%.

It explained that trading in the first quarter reflected the ongoing challenges to discretionary consumer spending, particularly those impacting on businesses serving the repair, maintenance and improvement sector.

Topps Tiles expects its full-year profit to be weighted towards the second half, based on a number of factors including the timing of the holiday pay accrual, higher energy usage in the first half and general trading in the first half.

On AIM, Angle soared 66%, after it unveiled "breakthrough" clinical results from DNA molecular analysis of cancer patient blood samples that "provide a unique insight into the progression of each patient's cancer and how this may be treated".

The medical diagnostics firm said the results "highlight the potential for the Parsortix system to identify key variants [of] DNA mutations missed by other approaches to help guide treatment decisions."

Stocks in New York were called higher. The Dow Jones Industrial Average, the S&P 500 index up and the Nasdaq Composite were all called up 0.2%.

On the US data calendar on Thursday, there is the ADP jobs report at 1315 GMT, a precursor to Friday's nonfarms. The latest initial jobless claims reading is at 1330 GMT, before a services PMI at 1445 GMT.

The data comes after minutes from the Federal Reserve's latest meeting were released overnight.

"Yesterday's FOMC minutes brought a little bit of something for everyone, with members expressing caution as they attempt to drive inflation back down to target. While they currently do not see any upside risk to inflation, there is a concern that they could stall the current disinflation should they pivot too swiftly. Nonetheless, the key takeaway is that they are looking at the six-month metric for the core PCE, which has already dropped below 2%," Scope Markets analyst Joshua Mahony commented.

"With that in mind, markets have remained highly dovish, expecting a whopping six rate cuts this year from the Fed. All eyes will now turn towards the US employment data, with today's ADP payrolls figure leading into tomorrow's jobs report. With Fed member Barkin speculating that a soft-landing looks increasingly likely, a gradual deterioration in the payrolls and unemployment rate could help put pressure on the FOMC to cut rates in March."

Gold was quoted at USD2,047.78 an ounce at midday on Thursday, higher than USD2,038.89 on Wednesday.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
13 May 2013 14:34

Angle shares jump on cell harvesting update

Shares in Angle, a specialist medtech company, leapt 20 per cent on Monday after the group said it has extended the operational capability of its Parsortix non-invasive cancer diagnostic product by automating its cell harvesting function. Harvesting is where captured tumour cells are recovered from

Read more
28 Feb 2013 13:36

Angle initiates launch of cancer diagnostic product for market research

Angle, an AIM-listed specialist medtech company, has initiated the launch of its Parsortix non-invasive cancer diagnostic product for the research market. The product is based on taking a blood test, and the system either counts circulating tumour cells (CTCs) in the blood or captures and recovers

Read more
31 Jan 2013 13:13

Angle raises funds with placing

Angle, a specialist medtech company, has placed 4.53m new ordinary shares at 50p each, representing a discount of 17.4 per cent on the mid-price of 60.50p per share at close of business on Wednesday. Net of costs, the placing raised £2.2m, which will be used to strengthen the company's financial p

Read more
15 Jan 2013 08:47

Angle jumps again after pay out

Medical technology firm Angle saw its shares jump for a second day in a row after it received cash due from the sale of its portfolio company Acoylte Biomedica. The 2007 sale led to a legal case over an earn-out provision, which saw former Acolyte shareholder, Porton Capital, take the buyer, 3M, to

Read more
14 Jan 2013 09:46

Angle gains on breakthrough in cancer diagnostic technology

Angle advanced more than 90 per cent Monday after the medtech company announced a major breakthrough in its cancer diagnostic product Parsotix. The AIM listed company said it had edged further in the development of Parsortix, a non-invasive technology which captures and counts rare circulating tu

Read more
10 Dec 2012 15:01

Sharp drop in Angle shares following business update

AIM-listed medtech company Angle revealed that Origio, a partner involved in the development of a technology patented as EmbryoSure, has decided to cease EmbryoSure studies in a business update on Monday. EmbryoSure is a technology being developed to assess the viability of embryos for transfer in

Read more
7 Jun 2012 13:59

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cya

Read more
30 Apr 2012 08:47

Small caps round-up: Westminster Group, Angle, Asterand

Defence technology firm Westminster Group said its investment in a West African airport was looking promising and that an initial aggregate $150m revenue forecast could be achieved by the contract's eight year break point rather than the full contract term of 15 years. "Should that be the case, the

Read more
23 Apr 2012 14:31

Small caps round up: Intandem, Digital Learning, Hornby ...

Intandem Films, the London and Los Angeles based international film group, will co-produce 10 Things I Hate About Life, and sell the film internationally. The company will also distribute the film in the UK. The script has been written and the film will be directed by Gil Junger, the director of the

Read more
17 Apr 2012 10:40

Angle success with ovarian cancer

Shares in technology investment firm Angle rose on Tuesday after it said its Parsortix cell separation device had passed an important milestone. The firm said that the device could now capture ovarian cancer cells, creating the possibility of developing an effective, non-invasive screening techniqu

Read more
11 Apr 2012 09:46

Small caps round-up: Top Level Domain, Transense, SkyePharma

Top Level Domain Holdings, which operates generic top-level domains, has revealed that is wholly-owned subsidiary, Minds and Machines, has been appointed by Dot London Domains (DLD), the official promotional organisation for London, to assist with DLD's application for the position of registry opera

Read more
15 Mar 2012 12:06

Small caps round-up: HMV, Corero, ANGLE ...

HMV Group, the struggling entertainment media seller, has confirmed that it is still pondering what to do with its live music business. HMV added that a number of parties have indicated an interest in acquiring the business. There has been press speculation recently about who might be interested in

Read more
26 Jan 2012 13:10

Angle raises £1.2m, swings to a half-year loss

Technology investment company ANGLE has raised £1.2m through a fundraising on the same that it revealed it had swung to a loss in the first half ended October 31st. The firm said on Thursday that investors will acquire up to 1,715,717 new ordinary shares in the company at a price of 70p per shar

Read more
23 Jan 2012 14:25

Angle makes important step in cancer technology

Angle's 90%-owned portfolio company, Parsortix, which specialises in medical diagnostics, has used its cell separation device to successfully capture circulating tumour cells (CTCs) in cancer patient blood. The Parsortix separation technology has already been used to capture cultured breast cancer

Read more
16 Dec 2011 10:37

Angle shares storm north on Parsortix lung cancer result

Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix. Parsortix, which specialises in medical diagnostics, has confirmed its cell separation device can "capture cultured lung cancer cells". This comes af

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.